AAAAAA

   
Results: 1-24 |
Results: 24

Authors: OVERTURF K ALDHALIMY M MANNING K OU CN FINEGOLD M GROMPE M
Citation: K. Overturf et al., EX-VIVO HEPATIC GENE-THERAPY OF A MOUSE MODEL OF HEREDITARY TYROSINEMIA TYPE-I, Human gene therapy, 9(3), 1998, pp. 295-304

Authors: GROMPE M OVERTURF K ALDHALIMY M FINEGOLD M
Citation: M. Grompe et al., THERAPEUTIC TRIALS IN THE MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I - A PROGRESS REPORT, Journal of inherited metabolic disease, 21(5), 1998, pp. 518-531

Authors: OVERTURF K ALDHALIMY M OU CN FINEGOLD M TANGUAY R LIEBER A KAY M GROMPE M
Citation: K. Overturf et al., ADENOVIRUS-MEDIATED GENE-THERAPY IN A MOUSE MODEL OF HEREDITARY TYROSINEMIA TYPE-I, Human gene therapy, 8(5), 1997, pp. 513-522

Authors: OVERTURF K ALDHALIMY M FINEGOLD M GROMPE M
Citation: K. Overturf et al., SERIAL TRANSPLANTATION REVEALS STEM-CELL LIKE REGENERATIVE POTENTIAL IN PARENCHYMAL MOUSE HEPATOCYTE, The FASEB journal, 11(3), 1997, pp. 604-604

Authors: OVERTURF K ALDHALIMY M OU CN FINEGOLD M GROMPE M
Citation: K. Overturf et al., SERIAL TRANSPLANTATION REVEALS THE STEM-CELL-LIKE REGENERATIVE POTENTIAL OF ADULT-MOUSE HEPATOCYTES, The American journal of pathology, 151(5), 1997, pp. 1273-1280

Authors: MANNING K ALDHALIMY M FINEGOLD M MONTAGUTELLI X GROMPE M
Citation: K. Manning et al., INHIBITION OF HOMOGENTISIC ACID OXIDASE AS A TREATMENT FOR A MURINE MODEL OF HT1, American journal of human genetics, 61(4), 1997, pp. 287-287

Authors: GROMPE M ALDHALIMY M OVERTURF K FINEGOLD M
Citation: M. Grompe et al., LONG-TERM DIETARY AND PHARMACOLOGICAL THERAPY OF MURINE TYROSINEMIA TYPE-I, American journal of human genetics, 61(4), 1997, pp. 1462-1462

Authors: OVERTURF K ALDHALIMY M FINEGOLD M GROMPE M
Citation: K. Overturf et al., EX-VIVO HEPATIC GENE-THERAPY CORRECTS A MOUSE MODEL OF HT1 AND PROVIDES A MODEL FOR HEPATIC STEM-CELL DELINEATION, American journal of human genetics, 61(4), 1997, pp. 2094-2094

Authors: OVERTURF K ALDHALIMY M TANGUAY R BRANTLY M OU CN FINEGOLD M GROMPE M
Citation: K. Overturf et al., HEPATOCYTES CORRECTED BY GENE-THERAPY ARE SELECTED IN-VIVO IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I (VOL 12, PG 266, 1996), Nature genetics, 12(4), 1996, pp. 458-458

Authors: OVERTURF K ALDHALIMY M TANGUAY R BRANTLY M OU CN FINEGOLD M GROMPE M
Citation: K. Overturf et al., HEPATOCYTES CORRECTED BY GENE-THERAPY ARE SELECTED IN-VIVO IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I, Nature genetics, 12(3), 1996, pp. 266-273

Authors: GROMPE M OVERTURF K ALDHALIMY M FINEGOLD M
Citation: M. Grompe et al., SERIAL TRANSPLANTATION REVEALS STEM-CELL LIKE REGENERATIVE POTENTIAL IN PARENCHYMAL MOUSE HEPATOCYTES, Hepatology, 24(4), 1996, pp. 519-519

Authors: OVERTURF K ALDHALIMY M GROMPE M FINEGOLD M
Citation: K. Overturf et al., SUCCESSFUL TREATMENT OF HEREDITARY TYROSINEMIA TYPE-1 IN A MOUSE MODEL BY HEPATOCELLULAR TRANSPLANTATION AND RETROVIRAL GENE DELIVERY, Laboratory investigation, 74(1), 1996, pp. 24-24

Authors: GROMPE M LINDSTEDT S ALDHALIMY M KENNAWAY NG PAPACONSTANTINOU J TORRESRAMOS CA OU CN FINEGOLD M
Citation: M. Grompe et al., PHARMACOLOGICAL CORRECTION OF NEONATAL LETHAL HEPATIC-DYSFUNCTION IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I, Nature genetics, 10(4), 1995, pp. 453-460

Authors: GROMPE M ALDHALIMY M
Citation: M. Grompe et M. Aldhalimy, RAPID NONRADIOACTIVE ASSAY FOR THE DETECTION OF THE COMMON FRENCH-CANADIAN TYROSINEMIA TYPE-1 MUTATION, Human mutation, 5(1), 1995, pp. 105-105

Authors: GROMPE M ALDHALIMY M OVERTURF K OU CN BURLINGAME T KANNAWAY NG LINDSTEDT S FINEGOLD M
Citation: M. Grompe et al., AN IMPROVED MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-1, Journal of cellular biochemistry, 1995, pp. 365-365

Authors: GROMPE M ALDHALIMY M OU CN BURLINGAME T KENNAWAY N LINDSTEDT S FINEGOLD M
Citation: M. Grompe et al., PHARMACOLOGICAL CORRECTION OF LETHAL NEONATAL HEPATIC-DYSFUNCTION IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I, Laboratory investigation, 72(1), 1995, pp. 3-3

Authors: OVERTURF IK ALDHALIMY M FINEGOLD M GROMPE M
Citation: Ik. Overturf et al., HEPATOCYTES CORRECTED BY GENE-THERAPY ARE SELECTED IN-VIVO IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE, American journal of human genetics, 57(4), 1995, pp. 188-188

Authors: GROMPE M ALDHALIMY M KENNAWAY N FINEGOLD M SORIANO P
Citation: M. Grompe et al., CREATION OF A MURINE MODEL OF FUMARYLACETOACTETATE DEFICIENCY, Journal of cellular biochemistry, 1994, pp. 196-196

Authors: GROMPE M ALDHALIMY M KENNAWAY NG FINEGOLD M SORIANO P
Citation: M. Grompe et al., CREATION OF A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I, Pediatric research, 35(4), 1994, pp. 10000152-10000152

Authors: GROMPE M STLOUIS M DEMERS SI ALDHALIMY M LECLERC B TANGUAY RM
Citation: M. Grompe et al., SINGLE MUTATION OF THE FUMARYLACETOACETATE HYDROLASE GENE IN FRENCH-CANADIANS WITH HEREDITARY TYROSINEMIA TYPE-I, The New England journal of medicine, 331(6), 1994, pp. 353-357

Authors: GROMPE M ALDHALIMY M
Citation: M. Grompe et M. Aldhalimy, MUTATIONS OF THE FUMARYLACETOACETATE HYDROLASE GENE IN 4 PATIENTS WITH TYROSINEMIA, TYPE-I, Human mutation, 2(2), 1993, pp. 85-93

Authors: GROMPE M ALDHALIMY M FINEGOLD M OU CN BURLINGAME T KENNAWAY NG SORIANO P
Citation: M. Grompe et al., LOSS OF FUMARYLACETOACETATE HYDROLASE IS RESPONSIBLE FOR THE NEONATALHEPATIC-DYSFUNCTION PHENOTYPE OF LETHAL ALBINO MICE, Genes & development, 7(12A), 1993, pp. 2298-2307

Authors: GROMPE M ALDHALIMY M KENNAWAY N FINEGOLD M SORIANO P
Citation: M. Grompe et al., CREATION OF A MOUSE MODEL OF FUMARYLACETOACETATE HYDROLASE DEFICIENCY, American journal of human genetics, 53(3), 1993, pp. 98-98

Authors: TANGUAY RM STLOUIS M DEMERS SI LECLERC B ALDHALIMY M GROMPE M
Citation: Rm. Tanguay et al., IDENTIFICATION OF A PREDOMINANT MUTATION IN HEREDITARY TYROSINEMIA TYPE-I PATIENTS FROM QUEBEC, American journal of human genetics, 53(3), 1993, pp. 954-954
Risultati: 1-24 |